The SWHR Alzheimer’s Policy Agenda was released in conjunction with Alzheimer’s Disease Awareness Month in November and serves as a resource for policymakers.
Takeaways from SWHR's Alzheimer's Disease Working Group highlight needs for improved disease education, research, and care equity for women impacted by Alzheimer’s, both as patients and caregivers.
During the July 26, 2022, “Taking Heed of Alzheimer’s Disease" briefing, disease stakeholders discussed research and treatment for AD and its disproportionate impact on women.
For Alzheimer's & Brain Awareness Month in June, SWHR launched an Alzheimer's disease fact sheet about the burden of disease faced by women.
June is Alzheimer’s & Brain Awareness Month, a time to bring awareness to and expand education around Alzheimer's and brain health, including its wide impact on women.
The SWHR Women’s Health Equity Initiative highlights statistics on women’s health in the United States, to improve health equity across disease states, conditions, and life stages.
Most of what we know about human health and disease is based on research on men. This is because, until the 1990s, women of reproductive age were actively excluded from most clinical trials. Thanks to efforts by many organizations, including ours, this is changing.
To prevent and treat Alzheimer’s disease, scientists need to better understand how the disease differs between women and men, according to a paper published June 12 in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.
Imaging provides a window into brain changes due to dementia decades before someone begins to show clinical symptoms of the disease. Volume of the brain gradually declines with advancing age, but this decline takes a faster course in people who experience more cognitive decline than is expected for their age and go on to develop dementia.